The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation
Zhang, Nianzhu2; Liu, Lu1; Fan, Ning1; Zhang, Qian2; Wang, Weijie2; Zheng, Mingnan3; Ma, Lingfei4; Li, Yan1; Shi, Lei2,5
刊名ONCOTARGET
2016-09-20
卷号7期号:38页码:61587-61600
关键词septin forchlorfenuron breast cancer invasion MAPK
ISSN号1949-2553
DOI10.18632/oncotarget.11402
文献子类Article
英文摘要Septins are a novel class of GTP-binding cytoskeletal proteins evolutionarily conserved from yeast to mammals and have now been found to play a contributing role in a broad range of tumor types. However, their functional importance in breast cancer remains largely unclear. Here, we demonstrated that pharmaceutical inhibition of global septin dynamics would greatly suppress proliferation, migration and invasiveness in breast cancer cell lines. We then examined the expression and subcellular distribution of the selected septins SEPT2 and SEPT7 in breast cancer cells, revealing a rather variable localization of the two proteins with cell cycle progression. To determine the role of both septins in mediating malignant behavior of cancer cells, we used RNA silencing to specifically deplete endogenous SEPT2 or SEPT7 in highly invasive breast cancer cell line MDA-MB-231. Our findings showed that SEPT2/7 depletion had virtually identical inhibitory effects on cellular proliferation, apoptosis, migration and invasion. Moreover, the opposite performance in migration and invasion was observed after enforced expression of SEPT2/7 in the same cell line. We further demonstrated MEK/ERK activation, but not other MAPKs and AKT, was positively correlated with the protein levels of SEPT2 and SEPT7. Additionally, in SEPT2/7-overexpressing cells, the MEK specific inhibitor U0126 was able to correct the high active status of MEK/ERK while normalizing the increased invasive behaviors of these cells. Taken together, these results strongly suggest that SEPT2 and SEPT7 are involved in breast carcinogenesis and may serve as valuable therapeutic targets for breast cancer.
资助项目National Natural Science Foundation of China[81402385] ; National Natural Science Foundation of China[81570236] ; doctoral Scientific Research Function of Liao Ning province[2014114] ; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry[00000000] ; State Key Laboratory of Drug Research[SIMM1601KF-14]
WOS关键词MAMMALIAN SEPTIN ; DOWN-REGULATION ; BRAIN-TUMORS ; EXPRESSION ; CELLS ; GROWTH ; ORGANIZATION ; PHOSPHORYLATION ; ANGIOGENESIS ; CILIOGENESIS
WOS研究方向Oncology ; Cell Biology
语种英语
出版者IMPACT JOURNALS LLC
WOS记录号WOS:000387164700059
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/275887]  
专题国家新药筛选中心
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Ma, Lingfei; Li, Yan; Shi, Lei
作者单位1.Dalian Med Univ, Coll Basic Med Sci, Dalian 116044, Liaoning, Peoples R China;
2.Dalian Med Univ, Inst Canc Stem Cell, Ctr Canc, Dalian 116044, Liaoning, Peoples R China;
3.Dalian Med Univ, Dalian Municipal Cent Hosp, Dept Gynecol & Obstet, Dalian 116033, Liaoning, Peoples R China;
4.Dalian Med Univ, Affiliated Hosp 1, Dalian 116011, Liaoning, Peoples R China;
5.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Nianzhu,Liu, Lu,Fan, Ning,et al. The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation[J]. ONCOTARGET,2016,7(38):61587-61600.
APA Zhang, Nianzhu.,Liu, Lu.,Fan, Ning.,Zhang, Qian.,Wang, Weijie.,...&Shi, Lei.(2016).The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation.ONCOTARGET,7(38),61587-61600.
MLA Zhang, Nianzhu,et al."The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation".ONCOTARGET 7.38(2016):61587-61600.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace